Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

New England Journal of Medicine - Tập 380 Số 1 - Trang 11-22 - 2019
Deepak L. Bhatt1, Philippe Gabríel Steg2,3, Michael Miller4, Eliot A. Brinton5, Terry A. Jacobson6, Steven Ketchum7, Ralph T. Doyle, Rebecca A. Juliano7, Lixia Jiao7, Craig Granowitz7, Jean‐Claude Tardif8, Christie M. Ballantyne9
1Brigham and Women’s Hospital Heart and Vascular Center and Harvard Medical School, Boston, and the Department of Medicine, Baylor College of Medicine
2Assistance Publique–Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris, and the Department of Medicine, Baylor College of Medicine
3National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, and the Department of Medicine, Baylor College of Medicine
4Department of Medicine, University of Maryland School of Medicine, Baltimore, and the Department of Medicine, Baylor College of Medicine
5Utah Lipid Center, Salt Lake City, and the Department of Medicine, Baylor College of Medicine
6Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta, and the Department of Medicine, Baylor College of Medicine
7Amarin Pharma, Bedminster, NJ, and the Department of Medicine, Baylor College of Medicine
8Montreal Heart Institute, Université de Montréal, Montreal, and the Department of Medicine, Baylor College of Medicine
9Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1001/jama.2010.1322

10.1016/j.jacc.2017.10.068

10.1016/j.jacc.2015.08.027

10.1056/NEJMoa040583

10.1093/eurheartj/ehu500

10.1161/CIRCOUTCOMES.115.002104

10.1210/jc.2018-00470

10.1111/dom.13537

10.1161/JAHA.118.008740

10.1016/j.jacc.2018.04.061

10.1056/NEJMoa1203859

10.1056/NEJMoa1804989

10.1001/jamacardio.2017.5205

10.1016/S0140-6736(07)60527-3

10.1002/clc.22692

10.1016/j.amjcard.2011.04.015

10.1016/j.amjcard.2012.05.031

10.1007/s40256-012-0002-3

10.1016/j.vph.2017.02.004

10.1016/j.bbamem.2016.10.002

10.1016/j.chemphyslip.2018.01.002

10.1001/jama.2013.280532

10.1136/bmj.317.7168.1309

10.1093/oxfordjournals.aje.a009523

10.5551/jat.5876

10.1016/j.prostaglandins.2016.07.007

10.1016/j.plefa.2018.01.001

10.1002/clc.23055

10.1161/CIRCRESAHA.114.302737

10.1016/j.ijcard.2014.08.055

10.1016/j.jjcc.2017.07.007

10.1016/j.atherosclerosis.2015.07.035

10.1056/NEJMoa1707914

10.1016/j.cmet.2017.09.022

10.1016/j.jacc.2017.09.001

10.1002/clc.22856

10.1056/NEJMoa1410489

10.1056/NEJMoa1801174

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 380 Số 1

11-22

Thông tin tác giả